Page 4 - Patrick Forde News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patients with stage 1–3 non-small cell lung cancer (NSCLC) given a combination immunotherapy prior to surgery (neoadjuvant) had a better major pathological response (10% or less residual cancer) when the cancer was removed than those who took a single immunotherapy agent alone, according to results of a novel multicenter phase 2 NeoCOAST platform trial that included two investigators from the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Institute for Cancer Immunotherapy.

'50 percent is a big deal in any disease, but certainly in a disease like lung cancer, which has typically been very resistant to therapies.'

The highly anticipated "Return of the Scorpion" International Pro/Am boxing championship, originally scheduled for May 21 at the National Gymnasium, has been officially postponed due to unexpected difficulties in the travel arrangements for the participants from Colombia.

Guyanese pugilist Alesha Jackman is set to enter the boxing ring on May 21 at the National Gymnasium for the 'Return of the Scorpio' Pro/Am Card.

Immunotherapy treatment with Opdivo before surgery improved recurrence-free survival and overall survival at five years in patients with non-small cell lung cancer.